Lopinavir/Ritonavir
- Generic Name
- Lopinavir/Ritonavir
The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy Volunteers
- Conditions
- HIVProtease InhibitorsFenofibrateHypertriglyceridemiaGlucuronosyltransferase
- First Posted Date
- 2010-06-22
- Last Posted Date
- 2019-12-09
- Target Recruit Count
- 25
- Registration Number
- NCT01148004
- Locations
- πΊπΈ
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Drug-Drug Interaction of Lopinavir/Ritonavir on Pitavastatin
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2010-01-27
- Last Posted Date
- 2021-06-22
- Lead Sponsor
- Kowa Research Institute, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT01057433
Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access
- Conditions
- HIV
- Interventions
- First Posted Date
- 2009-10-29
- Last Posted Date
- 2017-05-11
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 710
- Registration Number
- NCT01003990
- Locations
- π΅π·
Clinical Research Puerto Rico, Inc., San Juan, Puerto Rico
πΊπΈSbma Research, Llc, Miami Beach, Florida, United States
πΊπΈSt Francis Memorial Hospital, San Francisco, California, United States
Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-Regimens
- Conditions
- HIV Infections
- Interventions
- Drug: Darunavir/ritonavir
- First Posted Date
- 2009-10-14
- Last Posted Date
- 2014-02-13
- Lead Sponsor
- Germans Trias i Pujol Hospital
- Target Recruit Count
- 73
- Registration Number
- NCT00994344
- Locations
- πͺπΈ
Germans Trias i Pujol Hospital, Badalona, Barcelona, Spain
πͺπΈHospital Universitario de Canarias, Santa Cruz de Tenerife, Canarias, Spain
Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women
- Conditions
- MalariaHIV Infections
- Interventions
- First Posted Date
- 2009-10-09
- Last Posted Date
- 2019-05-14
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 389
- Registration Number
- NCT00993031
- Locations
- πΊπ¬
Tororo District Hospital, Tororo, Uganda
Pharmacokinetics of Lopinavir/Ritonavir at Three Different Doses.
- First Posted Date
- 2009-09-28
- Last Posted Date
- 2011-03-29
- Lead Sponsor
- Kirby Institute
- Target Recruit Count
- 22
- Registration Number
- NCT00985543
- Locations
- π¬π§
St Stephen's Centre, Chelsea and Westminster Hospital, London, United Kingdom
Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected Patients
- Conditions
- HIV Infections
- Interventions
- Drug: efavirenz/emtricitabin/tenofovir
- First Posted Date
- 2009-07-27
- Last Posted Date
- 2014-06-24
- Lead Sponsor
- French National Agency for Research on AIDS and Viral Hepatitis
- Target Recruit Count
- 420
- Registration Number
- NCT00946595
- Locations
- π«π·
Service des maladies infectieuses et tropicales Hopital Saint-Antoine, Paris, France
Safety and Tolerability Study to Evaluate Lower Dose of GSK2248761 in Antiretroviral Treatment-Naive HIV-1 Infected Adults.
- Conditions
- Infection, Human Immunodeficiency Virus
- Interventions
- First Posted Date
- 2009-07-24
- Last Posted Date
- 2018-11-29
- Lead Sponsor
- ViiV Healthcare
- Target Recruit Count
- 8
- Registration Number
- NCT00945282
- Locations
- π¦π·
GSK Investigational Site, Buenos Aires, Argentina
Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs
- Conditions
- Healthy SubjectsInfection, Human Immunodeficiency Virus
- Interventions
- Drug: darunavir/ritonavir
- First Posted Date
- 2009-06-15
- Last Posted Date
- 2010-11-03
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 24
- Registration Number
- NCT00920088
- Locations
- πΊπΈ
GSK Investigational Site, Baltimore, Maryland, United States
GSK1349572 Drug Interaction With Etravirine and Either Darunavir/Ritonavir or Lopinavir/Ritonavir
- Conditions
- Healthy Volunteer
- Interventions
- First Posted Date
- 2009-03-23
- Last Posted Date
- 2012-02-22
- Lead Sponsor
- ViiV Healthcare
- Target Recruit Count
- 17
- Registration Number
- NCT00867152
- Locations
- πΊπΈ
GSK Investigational Site, Buffalo, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.